Transcode Therapeutics, Inc. (RNAZ) stock
RNAZNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.41+0.06 (+4.44%)
Close on Nov 17, 2026Market cap $1.43MP/E –Yield –
Transcode Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Transcode Therapeutics's market cap was $1.42M on Nov 11, 2026, against $7.74M a year earlier. Over the last 5 years it ranged from $418.48K to $1.37T, with a median of $3.79B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.42M | -75.1% |
| 2025 | Dec 31, 2025 | $5.69M | -99.7% |
| 2024 | Dec 31, 2024 | $1.63B | -97.5% |
| 2023 | Dec 29, 2023 | $65.11B | -79.8% |
| 2022 | Dec 30, 2022 | $322.87B | -73.4% |
| 2021 | Dec 31, 2021 | $1.21T | – |
See a number that looks wrong?